MORRISVILLE, N.C.--(BUSINESS WIRE)--May 17, 2006--BioDelivery Sciences International, Inc. (NASDAQ:BDSI - News): Conversion of Refundable Deposit on BEMA(TM) Fentanyl Development Transaction to Equity at $3.50 Per Share, a 40 % Premium to the May 16, 2006 Closing Price, Adds $7 Million to Stockholders’ Equity and Raises Additional $4.2 Million in Cash.
